HEADER TRANSFERASE 26-FEB-13 4JEF TITLE CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE Y202A IN INACTIVE TITLE 2 CONFORMATION. COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TS, TSASE; COMPND 5 EC: 2.1.1.45; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYMS, TS, OK/SW-CL.29; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INACTIVE FORM OF HUMAN THYMIDYLATE SYNTHASE, HOT SPOT RESIDUE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.TOCHOWICZ,R.M.STROUD,R.C.WADE REVDAT 2 06-MAY-15 4JEF 1 JRNL REVDAT 1 20-AUG-14 4JEF 0 JRNL AUTH O.M.SALO-AHEN,A.TOCHOWICZ,C.POZZI,D.CARDINALE,S.FERRARI, JRNL AUTH 2 Y.BOUM,S.MANGANI,R.M.STROUD,P.SAXENA,H.MYLLYKALLIO, JRNL AUTH 3 M.P.COSTI,G.PONTERINI,R.C.WADE JRNL TITL HOTSPOTS IN AN OBLIGATE HOMODIMERIC ANTICANCER TARGET. JRNL TITL 2 STRUCTURAL AND FUNCTIONAL EFFECTS OF INTERFACIAL MUTATIONS JRNL TITL 3 IN HUMAN THYMIDYLATE SYNTHASE. JRNL REF J.MED.CHEM. V. 58 3572 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25798950 JRNL DOI 10.1021/ACS.JMEDCHEM.5B00137 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.1_743) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 19569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 1003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.0065 - 4.4181 0.99 2773 147 0.1637 0.1791 REMARK 3 2 4.4181 - 3.5077 1.00 2670 139 0.1676 0.1888 REMARK 3 3 3.5077 - 3.0645 1.00 2668 126 0.1967 0.2769 REMARK 3 4 3.0645 - 2.7844 1.00 2626 166 0.2247 0.3296 REMARK 3 5 2.7844 - 2.5849 1.00 2596 152 0.2098 0.2773 REMARK 3 6 2.5849 - 2.4325 1.00 2632 146 0.2492 0.2842 REMARK 3 7 2.4325 - 2.3107 0.98 2601 127 0.3015 0.3790 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 57.84 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.690 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.70710 REMARK 3 B22 (A**2) : -0.70710 REMARK 3 B33 (A**2) : 1.41420 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2080 REMARK 3 ANGLE : 1.128 2812 REMARK 3 CHIRALITY : 0.070 299 REMARK 3 PLANARITY : 0.005 358 REMARK 3 DIHEDRAL : 15.507 783 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: all REMARK 3 ORIGIN FOR THE GROUP (A): 29.4320 -35.6394 2.2998 REMARK 3 T TENSOR REMARK 3 T11: 0.3254 T22: 0.3934 REMARK 3 T33: 0.3416 T12: -0.1046 REMARK 3 T13: 0.0609 T23: -0.0014 REMARK 3 L TENSOR REMARK 3 L11: 3.2190 L22: 4.4700 REMARK 3 L33: 3.7635 L12: 0.8241 REMARK 3 L13: -0.3852 L23: -0.0724 REMARK 3 S TENSOR REMARK 3 S11: -0.0761 S12: 0.2712 S13: 0.0479 REMARK 3 S21: -0.4928 S22: 0.1930 S23: -0.3716 REMARK 3 S31: 0.1494 S32: 0.1307 S33: -0.1060 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4JEF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-MAR-13. REMARK 100 THE RCSB ID CODE IS RCSB077941. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-08 REMARK 200 TEMPERATURE (KELVIN) : 273.0 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.115879 REMARK 200 MONOCHROMATOR : KHOZU DOUBLE FLAT CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19623 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 37.002 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.0 M AMMONIUM SULPHATE, 20 UM BETA- REMARK 280 ME, 0.1 M MES, 5% (W/V) PEG 400, PH 6.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.54967 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 55.09933 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 55.09933 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.54967 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -86.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 27.54967 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 103 REMARK 465 LYS A 104 REMARK 465 GLY A 105 REMARK 465 VAL A 106 REMARK 465 LYS A 107 REMARK 465 ILE A 108 REMARK 465 TRP A 109 REMARK 465 ASP A 110 REMARK 465 ALA A 111 REMARK 465 ASN A 112 REMARK 465 GLY A 113 REMARK 465 SER A 114 REMARK 465 ARG A 115 REMARK 465 ASP A 116 REMARK 465 PHE A 117 REMARK 465 LEU A 118 REMARK 465 ASP A 119 REMARK 465 SER A 120 REMARK 465 LEU A 121 REMARK 465 GLY A 122 REMARK 465 PHE A 123 REMARK 465 SER A 124 REMARK 465 THR A 125 REMARK 465 ARG A 126 REMARK 465 GLU A 127 REMARK 465 GLU A 128 REMARK 465 GLY A 129 REMARK 465 ASP A 130 REMARK 465 GLY A 143 REMARK 465 ALA A 144 REMARK 465 GLU A 145 REMARK 465 TYR A 146 REMARK 465 ARG A 147 REMARK 465 ASP A 148 REMARK 465 MET A 149 REMARK 465 GLU A 150 REMARK 465 SER A 151 REMARK 465 ASP A 152 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ALA A 98 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 99 N CA C O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 199 CB CYS A 199 SG -0.098 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 80 73.51 -69.16 REMARK 500 ASN A 97 108.80 -166.06 REMARK 500 ALA A 98 -171.73 -65.15 REMARK 500 LYS A 99 -42.10 60.95 REMARK 500 GLU A 100 -13.10 -47.17 REMARK 500 TYR A 135 42.99 76.21 REMARK 500 ASN A 171 79.56 -159.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4E28 RELATED DB: PDB REMARK 900 HUMAN THYMIDYLATE SYNTHASE IN INACTIVE CONFORMATION. REMARK 900 RELATED ID: 3EGY RELATED DB: PDB REMARK 900 VARIANTS OF HUMAN THYMIDYLATE SYNTHASE WITH LOOP 181-197 REMARK 900 STABILIZED IN THE INACTIVE CONFORMATION. REMARK 900 RELATED ID: 3EHI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE M190K WITH REMARK 900 LOOP 181-197 STABILIZED IN INACTIVE CONFORMATION. REMARK 900 RELATED ID: 4FGT RELATED DB: PDB REMARK 900 ALLOSTERIC PEPTIDIC INHIBITOR OF HUMAN THYMIDYLATE SYNTHASE REMARK 900 THAT STABILIZES INACTIVE CONFORMATION OF THE ENZYME. DBREF 4JEF A 26 311 UNP P04818 TYSY_HUMAN 26 311 SEQADV 4JEF ALA A 202 UNP P04818 TYR 202 ENGINEERED MUTATION SEQRES 1 A 286 PRO PRO HIS GLY GLU LEU GLN TYR LEU GLY GLN ILE GLN SEQRES 2 A 286 HIS ILE LEU ARG CYS GLY VAL ARG LYS ASP ASP ARG THR SEQRES 3 A 286 GLY THR GLY THR LEU SER VAL PHE GLY MET GLN ALA ARG SEQRES 4 A 286 TYR SER LEU ARG ASP GLU PHE PRO LEU LEU THR THR LYS SEQRES 5 A 286 ARG VAL PHE TRP LYS GLY VAL LEU GLU GLU LEU LEU TRP SEQRES 6 A 286 PHE ILE LYS GLY SER THR ASN ALA LYS GLU LEU SER SER SEQRES 7 A 286 LYS GLY VAL LYS ILE TRP ASP ALA ASN GLY SER ARG ASP SEQRES 8 A 286 PHE LEU ASP SER LEU GLY PHE SER THR ARG GLU GLU GLY SEQRES 9 A 286 ASP LEU GLY PRO VAL TYR GLY PHE GLN TRP ARG HIS PHE SEQRES 10 A 286 GLY ALA GLU TYR ARG ASP MET GLU SER ASP TYR SER GLY SEQRES 11 A 286 GLN GLY VAL ASP GLN LEU GLN ARG VAL ILE ASP THR ILE SEQRES 12 A 286 LYS THR ASN PRO ASP ASP ARG ARG ILE ILE MET CME ALA SEQRES 13 A 286 TRP ASN PRO ARG ASP LEU PRO LEU MET ALA LEU PRO PRO SEQRES 14 A 286 CME HIS ALA LEU CYS GLN PHE ALA VAL VAL ASN SER GLU SEQRES 15 A 286 LEU SER CYS GLN LEU TYR GLN ARG SER GLY ASP MET GLY SEQRES 16 A 286 LEU GLY VAL PRO PHE ASN ILE ALA SER TYR ALA LEU LEU SEQRES 17 A 286 THR TYR MET ILE ALA HIS ILE THR GLY LEU LYS PRO GLY SEQRES 18 A 286 ASP PHE ILE HIS THR LEU GLY ASP ALA HIS ILE TYR LEU SEQRES 19 A 286 ASN HIS ILE GLU PRO LEU LYS ILE GLN LEU GLN ARG GLU SEQRES 20 A 286 PRO ARG PRO PHE PRO LYS LEU ARG ILE LEU ARG LYS VAL SEQRES 21 A 286 GLU LYS ILE ASP ASP PHE LYS ALA GLU ASP PHE GLN ILE SEQRES 22 A 286 GLU GLY TYR ASN PRO HIS PRO THR ILE LYS MET GLU MET MODRES 4JEF CME A 180 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4JEF CME A 195 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 180 10 HET CME A 195 10 HET SO4 A 401 5 HET SO4 A 402 5 HET SO4 A 403 5 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM SO4 SULFATE ION FORMUL 1 CME 2(C5 H11 N O3 S2) FORMUL 2 SO4 3(O4 S 2-) FORMUL 5 HOH *24(H2 O) HELIX 1 1 GLY A 29 GLY A 44 1 16 HELIX 2 2 PHE A 80 LYS A 93 1 14 HELIX 3 3 ASP A 159 ASN A 171 1 13 HELIX 4 4 ARG A 185 MET A 190 1 6 HELIX 5 5 LEU A 221 GLY A 242 1 22 HELIX 6 6 HIS A 261 LEU A 269 1 9 HELIX 7 7 LYS A 287 PHE A 291 5 5 HELIX 8 8 LYS A 292 GLU A 294 5 3 SHEET 1 A 6 VAL A 45 LYS A 47 0 SHEET 2 A 6 THR A 55 SER A 66 -1 O SER A 57 N VAL A 45 SHEET 3 A 6 LYS A 244 TYR A 258 -1 O PHE A 248 N TYR A 65 SHEET 4 A 6 GLU A 207 ASP A 218 1 N CYS A 210 O ILE A 249 SHEET 5 A 6 ALA A 197 VAL A 204 -1 N GLN A 200 O GLN A 211 SHEET 6 A 6 ILE A 178 ALA A 181 -1 N MET A 179 O CYS A 199 SHEET 1 B 2 LYS A 278 ILE A 281 0 SHEET 2 B 2 PHE A 296 GLU A 299 -1 O GLU A 299 N LYS A 278 LINK C MET A 179 N CME A 180 1555 1555 1.33 LINK C CME A 180 N ALA A 181 1555 1555 1.33 LINK C PRO A 194 N CME A 195 1555 1555 1.33 LINK C CME A 195 N HIS A 196 1555 1555 1.32 CISPEP 1 GLY A 94 SER A 95 0 -2.52 SITE 1 AC1 7 ARG A 50 ARG A 78 ARG A 176 ARG A 185 SITE 2 AC1 7 LEU A 189 PRO A 305 THR A 306 SITE 1 AC2 6 ARG A 50 ARG A 175 ASN A 183 HIS A 196 SITE 2 AC2 6 ARG A 215 SER A 216 SITE 1 AC3 3 GLU A 272 ARG A 274 HIS A 304 CRYST1 95.955 95.955 82.649 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010422 0.006017 0.000000 0.00000 SCALE2 0.000000 0.012034 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012099 0.00000